Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (351-360 of 590) with videos related to

Pageof 59
Sort By:
Joint Commission Journal on Quality and Patient Safety|February 19, 2008
Medication errors associated with code situations in U.S. hospitals: direct and collateral damageAngela K M Lipshutz, Laura L Morloc, Andrew D Shore, et al.
The American Journal of Physiology|July 1, 1997
Left ventricular parallel conductance during cardiac cycle in children with congenital heart diseaseP A White, R R Chaturvedi, D Shore, et al.
The Journal of Biological Chemistry|April 15, 1992
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive centerP M Sherman, D A Lawrence, A Y Yang, et al.
Advances in Therapy|November 28, 2025
Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'Mehmet A Bilen, Benjamin Lowentritt, Ibrahim Khilfeh, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Advances in Therapy|May 29, 2025
Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Benjamin Lowentritt, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|May 9, 2025
Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USABenjamin Lowentritt, Mehmet A Bilen, Ibrahim Khilfeh, et al.
Nature|December 10, 1999
Chromosomal landscape of nucleosome-dependent gene expression and silencing in yeastJ J Wyrick, F C Holstege, E G Jennings, et al.
Alzheimer Disease and Associated Disorders|March 7, 2003
Identifying dementia in high-risk community samples: the memory and medical care studyBetty Smith Black, Judith Kasper, Jason Brandt, et al.
Diseases of the Colon and Rectum|November 10, 2011
Readmission rates and cost following colorectal surgeryElizabeth C Wick, Andrew D Shore, Kenzo Hirose, et al.
Pageof 59

Showing results (351-360 of 590) with videos related to

Sort By:
Pageof 59
Joint Commission Journal on Quality and Patient Safety|February 19, 2008
Medication errors associated with code situations in U.S. hospitals: direct and collateral damageAngela K M Lipshutz, Laura L Morloc, Andrew D Shore, et al.
The American Journal of Physiology|July 1, 1997
Left ventricular parallel conductance during cardiac cycle in children with congenital heart diseaseP A White, R R Chaturvedi, D Shore, et al.
The Journal of Biological Chemistry|April 15, 1992
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive centerP M Sherman, D A Lawrence, A Y Yang, et al.
Advances in Therapy|November 28, 2025
Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'Mehmet A Bilen, Benjamin Lowentritt, Ibrahim Khilfeh, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Advances in Therapy|May 29, 2025
Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate CancerMehmet A Bilen, Benjamin Lowentritt, Ibrahim Khilfeh, et al.
Journal of Comparative Effectiveness Research|May 9, 2025
Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USABenjamin Lowentritt, Mehmet A Bilen, Ibrahim Khilfeh, et al.
Nature|December 10, 1999
Chromosomal landscape of nucleosome-dependent gene expression and silencing in yeastJ J Wyrick, F C Holstege, E G Jennings, et al.
Alzheimer Disease and Associated Disorders|March 7, 2003
Identifying dementia in high-risk community samples: the memory and medical care studyBetty Smith Black, Judith Kasper, Jason Brandt, et al.
Diseases of the Colon and Rectum|November 10, 2011
Readmission rates and cost following colorectal surgeryElizabeth C Wick, Andrew D Shore, Kenzo Hirose, et al.
Pageof 59